Large distribution CBDfx already sells in over 25,000 distribution points across 21 countries, indicating strong wholesale and retail appeal. Potential sales opportunity: pursue expanded OD/retail partnerships, regional distributors, and flagship store collaborations to increase shelf presence and drive volume.

CGMP Transparency Products are manufactured in CGMP facilities with third-party lab reports and QR traceability. Potential sales opportunity: leverage verified quality assurances in pitches to retailers and wellness clinics seeking trusted CBD SKUs with clear provenance and safety documentation.

Product breadth Portfolio includes tinctures, topicals, gummies, capsules, and new lines such as full-spectrum with Delta-9. Potential sales opportunity: cross-sell to multi-category retailers, co-promotions with gyms, spas, and beauty channels, and targeted bundles for wellness and sleep categories.

Recent partnerships Recent collaboration with Talker Research on stress and CBD/THC efficacy signals active consumer insights and research-backed messaging. Potential sales opportunity: position CBDfx as a data-informed partner for health and wellness retailers seeking evidence-driven marketing and consumer education programs.

Growth signals Revenue range estimated at $25M-$50M with a history of product launches and recognition in vape and wellness spaces. Potential sales opportunity: engage mid-market and regional retailers looking to scale with a proven, reputable CBD brand that has brand equity and growth momentum.